Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology.
Mansbach. Jonathan M JM; Hasegawa. Kohei K; Ajami. Nadim J NJ; Petrosino. Joseph F JF; Piedra. Pedro A PA; Tierney. Courtney N CN; Espinola. Janice A JA; Camargo. Carlos A CA
Key Findings
- Infants in the lowest LLā37 quartile had a higher chance of intensive care use (aORāÆāāÆ2)
- Lower LLā37 levels were associated with longer hospital stays
- Low LLā37 was linked to RSV infection, whereas higher LLā37 was linked to rhinovirus
Practical Outcomes
- The study suggests that LLā37 levels reflect how severe bronchiolitis can get, especially with RSV. While it hints that boosting LLā37 might help, thereās no direct evidence or protocol for supplementation in adults or biohackers yet. For now, itās mainly a biomarker insight rather than an actionable intervention.
Summary
In a big study of over a thousand babies with bronchiolitis, kids with the lowest blood levels of the immune peptide LLā37 were almost twice as likely to need intensive care and stayed in the hospital longer. Low LLā37 also showed a strong link to infection by RSV, the most common cause of bronchiolitis, while higher LLā37 was tied to the less severe rhinovirus.
Abstract
LL-37 is a host defense peptide with antimicrobial and immunomodulatory properties. We examined the relation of serum LL-37 levels to the severity of bronchiolitis and viral etiology. We performed a 17-center prospective cohort study in infants hospitalized with bronchiolitis over 3 winters (2011-2014). Site teams collected clinical data, nasopharyngeal aspirates and serum. We used real-time polymerase chain reaction to test nasopharyngeal aspirates for 16 viruses. We tested serum for LL-37. Severity of bronchiolitis was defined by intensive care use and hospital length of stay. Viral etiology was defined as respiratory syncytial virus (RSV) or rhinovirus (RV), including coinfections with other viruses. The median age of the 1005 enrolled infants was 3 months (interquartile range, 2-6 months). After adjustment for 12 variables, LL-37 levels in the lowest quartile, compared with the highest, were associated both with intensive care use (adjusted odds ratio [aOR], 1.97; P = .01) and longer hospital stay (1.34; P < .001). In separate multivariable models, infants with LL-37 levels in the lowest 3 quartiles, compared with the highest, were more likely to have RSV (eg, aOR, 2.6 [lowest quartile]; P < .001 [all quartiles]). By contrast, infants with the lowest 3 LL-37 quartiles were less likely to have RV (eg, aOR, 0.5 [lowest quartile]; Pall quartiles ≤ .03 [all quartiles]). In a large multicenter study of infants hospitalized with bronchiolitis, lower levels of serum LL-37 were associated with increased severity of illness. There was also an inverse relationship between LL-37 levels and the most common virus causing bronchiolitis, RSV. These findings highlight the role of LL-37 in the pathogenesis of bronchiolitis.
Study Information
pubmed
2017
2017-09-15T00:00:00.000Z
10.1093/cid/cix483
27
38